Financhill
Back

Acelyrin Stock Predictions

Acelyrin Stock Forecast

  • Is Acelyrin Stock Undervalued?
    The current Acelyrin [SLRN] share price is $2.17. The Score for SLRN is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • SLRN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Acelyrin Stock Go Up Next Year?

Data Unavailable

Acelyrin Stock Rating

Data Unavailable

Acelyrin Stock Price History

Is SLRN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLRN is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
acelyrin.com

52-Week Data

52-Week High:
7.25
52-Week Low:
1.85

Prediction Charts

Market Cap:
218.5M
Price in USD:
2.17
Volume:
474.9K
Beta:
1.17

Technical Analysis

SMA50:
2.47
SMA100:
2.64
SMA200:
3.99
52-Wk Change:
-48.82%

Stock Predictions

  • Is Acelyrin stock public?
    Yes, Acelyrin is a publicly traded company.
  • What is the Acelyrin stock quote today?
    The Acelyrin stock price is 2.17 USD today.
  • How to buy Acelyrin stock online?
    You can buy Acelyrin shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-7 2.35 2.31 2.53 2.22
Apr-8 2.37 2.08 2.47 2.03
Apr-9 2.14 2.18 2.26 2.07
Apr-10 2.18 2.15 2.18 2.05
Apr-11 2.15 2.23 2.26 2.14
Apr-14 2.27 2.18 2.32 2.17
Apr-15 2.16 2.23 2.24 2.10
Apr-16 2.24 2.20 2.24 2.19
Apr-17 2.19 2.20 2.23 2.17
Apr-21 2.18 2.28 2.31 2.18
Apr-22 2.30 2.34 2.35 2.27
Apr-23 2.46 2.25 2.49 2.23
Apr-24 2.31 2.17 2.31 2.13
Apr-25 2.14 2.17 2.20 2.08

Acelyrin Earnings

Data Unavailable

Acelyrin Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.42 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.39 per share.

* Acelyrin stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.